Welcome to the CorTechs Labs Resource Center

Whether you need assistance or want to learn more about how our products are being used, our support team and resource center are here to help.

Technical Support
Monday – Friday
8 am to 5 pm PT
+1-858-459-9700, Extension 2


Mild Cognitive Impairement: Baseline and Longitudinal Structural MR Imaging Measures Improve Predicitve Prognosis

To assess whether single-time-point and longitudinal volumetric magnetic resonance (MR) imaging measures provide predictive prognostic information in patients with amnestic mild cognitive impairment (MCI). Radiology, June 2011.

Mesial Temporal Sclerosis: Accuracy Of NeuroQuant Versus Neuroradiologist

A study to compare the accuracy of a volumetric fully automated computer assessment of hippocampal volume asymmetry versus neuroradiologists’ interpretations of the temporal lobes for mesial temporal sclerosis (MTS), which is important for patients with temporal lobe epilepsy. American Journal of Neuroradiology, 2015 April 23.

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

Study to determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). 2011 October 12.

Fully-automated Volumetric MRI With Normative Ranges- Translation To Clinical Practice

An article published in Behavioral Neurology (2009), “Fully-Automated volumetric MRI with Normative Ranges: Translation to Clinical Practice,” explains how NeuroQuant®’s fully-automated volumetric MRI capabilities with normative ranges can facilitate wider implementation of volumetric MRI beyond the academic setting.

An Expanded Role For Neuroimaging In The Evaluation Of Memory Impairment

Authors Rahul Desikan et al from UCSD and UCSF describe a strategy to incorporate newly available imaging markers in the workup of memory problems, emphasizing that evidence of neurodegeneration can be an important piece of the puzzle to guide further management and testing, while helping to avoid overuse of more expensive biomarker tests. The paper highlights the way in which advanced neuroimaging tools such as CorTechs Labs’ NeuroQuant® volumetric MRI analysis system can provide information key to an improved understanding of the patient’s clinical status. (AJNR Am J Neuroradiology originally published online on June 13, 2013, 10.3174/ajnr.A3644)

Biomarkers For The Clinical Evaluation Of The Cognitively Impaired Elderly, Amyloid Is Not Enough

Recently published in the journal Imaging in Medicine (June, 2012), Linda K. McEvoy and James B. Brewer argue that while incorporating biomarkers for assessing Alzheimer’s disease risk (including volumetric MRI done with NeuroQuant®) can help in patient prognosis, tests for amyloid, if used in isolation, have potential for harm, as amyloid tests are clinically useful only when evidence suggests progressive cognitive decline or neurodegeneration. (Imaging in Medicine, June 2012, Vol. 4, No. 3 , Pages 343-357).

Structural Functional And Molecular Neuroimaging Biomarkers For Alzheimers Disease

Neuroimaging biomarkers are now routinely incorporated into AD clinical trials and are increasingly used in clinical practice. This paper broadly describes the development and use of these biomarkers as they relate to AD.

High-throughput, Fully Automated Volumetry For Prediction Of MMSE And CDR Decline In Mild Cognitive Impairment

Scientists at the University of California, San Diego School of Medicine have shown that NeuroQuant®’s fully-automated volumetric MRI scanning is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer’s disease. The procedure can be readily used in clinics to measure brain atrophy, and may help physicians to predict decline in MCI patients.

Neuroradiology: Quantitative MR Volumetry In Temporal Lobe Epilepsy

Quantitative MR imaging using NeuroQuant® can enhance standard visual analysis, providing a viable means for translating volumetric analysis into clinical practice and increasing the detection of hippocampal atrophy in temporal lobe epilepsy in both community and tertiary care settings. Radiology August 2012 264:542-550; Published online June 21, 2012.

Amygdala Volume Changes In Posttraumatic Stress Disorder In A Large Case-Controlled Veterans Group

Assessment of military veterans with PTSD and trauma-exposed control subjects, with sufficient power to perform a definitive assessment of the effect of PTSD on volumetric changes in the amygdala and hippocampus and of the contribution of illness duration, trauma load, and depressive symptoms. November 2012.

Prospective Longitudinal MRI Study Of Brain Volumes And Diffusion Changes During The 1 First Year After Moderate To Severe Traumatic Brain Injury

Prospective study of TBI patients to investigate volume change in cortical grey matter (GM), hippocampus, lenticular nucleus, lobar white matter (WM), brainstem and ventricles.